News

As per the agreement, AstraZeneca will have access to injectable medicines used to treat infections and will make them available to patients in China. On completion of the

The 50/50 JV combines Microsoft’s platform expertise with GE Healthcare’s experience in clinical and administrative workflow solutions The JV will develop and market an open, interoperable technology platform

As part of the deal, Molecular Partners and Janssen Biotech will jointly develop DARPins and examine their use to address diseases where there is unmet needs for effective

Pycnogenol is an antioxidant plant extract from the bark of the French maritime pine tree. The study examined 53 Italian university students, aged 18-27, who were given 100

The Phase 3 program includes two randomized, double-blind, placebo-controlled studies, ULISES 007 and ULISES 008. The objective is to evaluate the efficacy and safety of daily 160 and

MelanPlus is believed to be a vitamin treatment for graying hair which addresses specific nutritional needs based on gender. According to the company, the new formulas contain Chinese

The multinational, prospective, randomized, double-blind study will evaluate the effectiveness of AMR101 in reducing the prevalence of first major cardiovascular events in a high-risk patient population. Amarin chairman

The facility, Unit-VI, has been granted approval for Cefotaxime sodium for injection, Ceftriaxone sodium for injection and Cefuroxime sodium for injection, indiainfoline.com reported. Following the approval, the company

The deal is believed to enforce VistaGen’s stem cell technology-based drug rescue activities using Synterys’ medicinal chemistry expertise. VistaGen’s drug rescue initiatives comprise its human pluripotent stem cell